StockData
Envoy Medical, Inc. logo

Envoy Medical, Inc. (COCHW) stock

COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 5/30
$0.03−0.00 (-15.49%)

Close on Oct 30, 2026Market cap $511.80MP/E –Yield –

Envoy Medical, Inc. saw revenue fall 6.8% to $207.00K over the twelve months to Jun 30, 2026. Free cash flow was -$18.38M. At the latest close the market valued the company at $511.80M.

Revenue
$207.00K
-6.8% vs. a year earlier
Operating income
-$23.62M
TTM Q2 2026
Free cash flow
-$18.38M
FY2025
EPS, diluted
-$0.77
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$511.80M
P/E ratio
–
Price to sales
2472.46
Price to book
154.95
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$207.00K
Net income
-$23.40M
EPS, diluted
-$0.77
Free cash flow
-$18.38M
Book value per share
$0.03
Diluted shares
104M

Trading

Next earnings
Nov 9, 2026 (estimated, before the open)
Previous close
$0.03
Open
$0.03
Day's range
$0.03 – $0.03
Volume
8,741
Average volume (20 days)
17,307
Beta (5 years)
-0.55
52-week range
$0.43 – $9.54
RSI (14 days)
55.0
Volatility (1 year)
6148.9%
Relative volume
0.24×
WACC
7.5%

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

PeriodCOCHWS&P 500DifferenceCOCHW per yearS&P 500 per year
1 month-20.3%-0.9%−19.4 pts
3 months-30.3%+2.1%−32.4 pts
Year to date-35.5%+11.7%−47.2 pts
1 year-39.8%+12.4%−52.2 pts
3 years+56.9%+88.6%−31.7 pts+16.2%+23.5%
5 years-96.2%+75.9%−172.1 pts-48.0%+12.0%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

$207.00K-6.8% YoY

Gross profit

-$798.00K

Operating income

-$23.62M

Net income

-$23.40M

EPS, diluted

-$0.77

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Envoy Medical filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Envoy Medical

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc. is a hearing health medical device company that develops implantable hearing technologies designed to utilize the natural anatomy of the ear. The company focuses on developing electrical and mechanical hearing systems across the hearing loss spectrum. Its key product development includes the Acclaim cochlear implant, a fully implanted investigational system featuring an implanted sensor, sound processor, and power source that captures sound without external, ear-worn components. The company also developed the Esteem fully implanted active middle ear implant. Its devices are designed for adult patients suffering from hearing loss, specifically targeting individuals with severe-to-profound sensorineural hearing loss who obtain limited benefit from conventional hearing aids.

Company profile, executives and history

Envoy Medical stock: common questions

What is Envoy Medical's stock price?

COCHW closed at $0.03 on Oct 30, 2026, down 15.49% on the day. Over the past 52 weeks it traded between $0.43 and $9.54.

What is Envoy Medical's market cap?

Envoy Medical was worth $511.80M at the close on Oct 30, 2026: the share price times the diluted shares outstanding.

What is COCHW's P/E ratio?

Envoy Medical lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.77), so it has no meaningful P/E ratio.

How much revenue does Envoy Medical make?

Envoy Medical reported revenue of $207.00K for the twelve months to Jun 30, 2026, down 6.8% from a year earlier.

Does Envoy Medical pay a dividend?

No. Envoy Medical has not paid a cash dividend over the last twelve months.

When does Envoy Medical report earnings next?

Envoy Medical is expected to report Q3 FY2026 results on Nov 9, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has COCHW stock performed over the past year?

Including dividends, COCHW returned -39.8% over the past year, against +12.4% for the S&P 500.

Who are Envoy Medical's competitors?

Companies most similar to Envoy Medical by business, industry and size include FEED, QTEX, NXL, GUTS, AVR.